OMCM Stock UPDATES Omnicomm Systems Inc (OMCM) 0.1450 09/18/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Omnicomm Systems Inc (OMCM) 0.1450 $OMCM

Leading In Vitro Diagnostics Company Selects OmniComm's(R) TrialMaster(R) Electronic Data Capture Solution
Marketwire - Wed Sep 17, 7:35AM CDT
OmniComm Systems, Inc. (OTCQB: OMCM), a global leading provider of clinical data management technology, is pleased to announce that a leading in vitro diagnostics (IVD) company has selected TrialMaster electronic data capture (EDC) to support its clinical evaluation of innovative IVD products for rapid identification and antibiotic susceptibility testing of infectious pathogens.

OmniComm Systems(R) Announces Record Contract Growth in First Half of 2014
Marketwire - Mon Aug 18, 7:00AM CDT
OmniComm Systems, Inc. (OTCQB: OMCM), a leading global provider of data management solutions for clinical trials, today announced it has achieved record contract growth through the first six months of 2014. The company has signed contracts with 3 of the top 5 global contract research organizations (CRO) during this period and 3 of the 10 top global pharmaceutical companies are now utilizing the benefits of OmniComm Systems' technology to help them advance medical research. During this period the company realized a 162% increase in total contract value as compared to the same period in 2013 with over 45% attributed to new clients.

Formedix and OmniComm Systems(R) Partnership Strengthened with the Release of Enhanced TrialMaster(R) Integration for EDC Build
PRWeb - Wed Jul 23, 11:04AM CDT
Last year, Formedix celebrated its partnership with OmniComm Systems, a leading global provider of data management solutions for clinical trials. The company launched its integration with TrialMaster, a leading-edge system for electronic data capture (EDC) and clinical data management. Formedix, a renowned provider of universal design and study execution tools added TrialMaster to its Transform for EDC product line. This latest, and much anticipated version of Transform for TrialMaster, is being released this week, in response to market demands for even tighter integration between these two prominent software products.

TFS, Top Sweden-Based Contract Research Organization, Selects OmniComm(R) TrialMaster(R) for Global Clinical Trial Research
Marketwire - Mon Jul 21, 8:18AM CDT
OmniComm Systems, Inc. (OTCQB: OMCM), a global leading provider of clinical data management technology, is pleased to announce that TFS International (TFS), the largest independent, global clinical contract research organization headquartered in Sweden, has selected TrialMaster electronic data capture (EDC) technology as its standard EDC solution for pivotal clinical trials. This whole process has been part of a company-wide initiative to provide TFS's clients around the globe with increased performance, functionality and better business decision making tools.

Leading Biotechnology Company Selects OmniComm Systems' R) TrialMaster(R)
Marketwire - Mon Jul 07, 10:32AM CDT
OmniComm Systems, Inc. (OTCQB: OMCM), a leading global provider of data management solutions for clinical trials, today announced that a leading biotechnology company, selected OmniComm's TrialMaster electronic data capture technology (EDC) to support three Phase III late stage clinical development studies. TrialMaster will be used for an open-labeled, multicenter, safety study and two randomized, double-blind, placebo-controlled efficacy and safety studies. OmniComm's proven technology and processes for integrating TrialMaster with other best-of-breed solutions was an important factor in selecting TrialMaster as their preferred EDC system. This leading biotechnology company will integrate TrialMaster with its preferred Interactive Response Technologies (IRT) solution. IRT solutions automate randomization and clinical supplies management and when integrated with TrialMaster EDC provides a comprehensive end-to-end solution.

OmniComm Systems(R) Signs Multi-Year Agreement With Top 5 Global CRO for TrialOne(R)
Marketwire - Wed Jun 25, 7:05AM CDT
OmniComm Systems, Inc. (OTCQB: OMCM), a leading global provider of clinical data management solutions for clinical trials, today announced that one of the world's largest contract research organizations selected TrialOne to standardize processes, improve business intelligence, ensure regulatory compliance, and achieve overall business transformation across all of its global Phase I clinics.

OmniComm(R) Systems Announces Major Milestone Achievement of Over 4,000 Clinical Trials
Marketwire - Tue Mar 25, 6:01AM CDT
OmniComm Systems, Inc. (OTCQB: OMCM), a global leading provider of clinical data management solutions for clinical trials, today announced its electronic data capture (EDC) solutions have been used in more than 4,000 live or completed clinical trials in over 55 countries across more than 30 therapeutic areas. The company's EDC solutions are widely accepted and utilized by pharmaceutical; biotechnology; contract research organizations; academic research centers and medical device companies of all sizes in all clinical trial phases. OmniComm's EDC technologies are embraced by the industry by significantly streamlining clinical processes through innovation, automation and interoperability.

Centre for Human Drug Research Selects OmniComm(R) Promasys(R) Mobile Technology
Marketwire - Wed Mar 19, 6:00AM CDT
OmniComm Systems, Inc. (OTCQB: OMCM) signed a five year agreement with Centre for Human Drug Research (CHDR), a clinical research center in The Netherlands, for Promasys mobile electronic data capture (EDC) technology. This agreement gives CHDR the ability to capture data right at the point-of-clinical testing utilizing the latest in mobile technology.

OmniComm(R) Systems Signs $2.5 Million Deal With Major Biotechnology Company
Marketwire - Mon Mar 17, 1:41PM CDT
OmniComm Systems, Inc. (OTCQB: OMCM) signed a $2.5 million contract for one Phase II and four Phase III global studies with a major east coast biotechnology company to supply OmniComm's market leading electronic data capture (EDC) technology, TrialMaster 4.2. TrialMaster EDC was selected in part for its award-winning Custom Data Export Utility. This enables compliance with FDA's, soon to be mandated, requirement for all clinical data submissions to conform to the Study Data Tabulation Model (SDTM). Conventional methodologies, used for clinical data submission, are very costly and typically take months to complete. TrialMaster's Custom Data Export Utility significantly decreases time to submission and can have SDTM data sets ready within 48 hours of database lock. TrialMaster's unique capability converts clinical study data to SDTM formats during trial conduct in real time, resulting in lower costs, decreased cycle times, and reduced rework.

Clinverse, Inc. Announces Strategic Partnership With OmniComm Systems, Inc.
PRWeb - Wed Sep 04, 9:03AM CDT
Clinverse, Inc., a global technology and eclinical commerce network for clinical trials, announced today it has formed a strategic partnership with OmniComm Systems, Inc., a leading provider of EDC solutions.

Top 5 Pharma Company Chooses OmniComm System's TrialMaster(R) EDC Solution for Late Phase Research
GlobeNewswire - Wed Aug 14, 7:30AM CDT
OmniComm Systems, Inc. (OTC:OMCM.OB), one of the fastest growing companies in the EDC marketplace, today announced that its TrialMaster(R) EDC solution has been selected by a top 5 pharmaceutical company to run a 5 year late-phase, non-interventional oncology trial.

Inflamax Research commits to use OmniComm eClinical Suite
M2 - Wed Jul 10, 10:09AM CDT
OmniComm Systems, Inc. (OTC: OMCM) said that Inflamax Research has made a five-year commitment to utilize OmniComm's eClinical Suite to further enhance their clinical operations.

Inflamax Research Selects OmniComm Systems' eClinical Suite to Enhance Clinical Operations
GlobeNewswire - Tue Jul 09, 8:03AM CDT
OmniComm Systems, Inc. (OTC:OMCM), one of the fastest growing companies in the Electronic Data Capture (EDC) marketplace, today announced that Inflamax Research, a full service Contract Research Organization (CRO), has made a 5 year commitment to utilize OmniComm's eClinical Suite to further enhance their clinical operations.

OmniComm Systems, Inc. Appoints Kuno van der Post, Ph.D. as Senior Vice President of Business Development
GlobeNewswire - Mon Jun 24, 7:30AM CDT
OmniComm Systems, Inc. (OTC:OMCM.OB), one of the fastest growing companies in the EDC marketplace, today announced that Kuno van der Post, Ph.D. has been promoted to Senior Vice President of Business Development.

OmniComm Systems, Inc. and Soltex Consulting, LLP Announce a Strategic Partnership
GlobeNewswire - Mon Jun 17, 8:05AM CDT
OmniComm Systems, Inc. (OMCM), one of the fastest growing companies in the Electronic Data Capture (EDC) marketplace, and Soltex Consulting, LLP, a leading eClinical lifecycle consulting firm, announced their new strategic partnership today. The partnership will allow OmniComm to offer best-in-class process reengineering and change management consulting to its EDC software customers, and augment OmniComm's own study build services, while allowing Soltex to offer its clients access to one of the most intuitive, productive EDC suites available on the market today.

E-Clinical Trial Technologies: Oracle Dominates - Global Strategic Business Report 2013-2018
M2 - Fri Jun 14, 9:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dsxrd3/eclinical_trial) has announced the addition of the "E-Clinical Trial Technologies - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for E-Clinical Trial Technologies in US$ Million by the following Product Segments: Electronic Data Capture (EDC) Solutions, Clinical Trial Management System (CTMS), mElectronic Patient Reported Outcome (ePRO), Randomization and Trial Supply Management (RTSM), and Interactive Response Technology (IRT). The report provides separate comprehensive analytics for the US, Canada, Europe, Asia Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. The report profiles 112 companies including many key and niche players such as: - Almac Group - ArisGlobal LLC - BioClinica - Clinipace Worldwide - Cmed Technology Ltd. - DATATRAK International, Inc. - DSG Inc. - DZS Software Solutions, Inc. - eClinForce, Inc. - e

Top 5 Pharma Company Signs 5-Year Multi-Million Dollar Agreement for OmniComm System's TrialOne Application Suite
GlobeNewswire - Mon Jun 03, 12:41PM CDT
OmniComm Systems, Inc. (OTC: OMCM.OB), one of the fastest growing companies in the EDC marketplace, today announced that its TrialOne(R) suite of applications has been chosen by a top 5 pharmaceutical company to automate their global clinical trial operations and processes in all their early-phase clinics.

Formedix and OmniComm Partner to Offer CRO and Sponsors Multi-Vendor EDC Capabilities
PRWeb - Tue Apr 30, 12:25PM CDT
Formedix, a leading provider of universal design and execution tools, has added to its rapidly growing Transform for Electronic Data Capture (EDC) product line. The partnership with OmniComm Systems, a full-service, global eClinical and EDC software and services company, provides integration with TrialMaster, a leading-edge system for Electronic Data Capture and Clinical Data Management.

Intersect ENT Selects OmniComm Systems' TrialMaster(R) EDC Solution
GlobeNewswire - Mon Apr 22, 7:30AM CDT
OmniComm Systems, Inc. (OTCBB:OMCM), a leading global provider of eClinical solutions, announced today that it was selected as the EDC System of choice by Menlo Park, CA based Intersect ENT for its RESOLVE Clinical Study, a Novel In-Office Treatment option for Chronic Sinusitis Patients.

OmniComm Systems, Inc. and Triumph Consultancy Services Announce a Strategic eClinical Partnership
GlobeNewswire - Mon Apr 15, 7:30AM CDT
OmniComm Systems, Inc. (OTC:OMCM), one of the fastest growing companies in the Electronic Data Capture (EDC) marketplace, and Triumph Consultancy Services (Triumph), a leading eClinical operations consulting firm, announced their new strategic partnership today. The partnership will allow OmniComm to offer their clients access to proven operational process optimization skills and extensive experience in clinical technology interoperability, while allowing Triumph to offer its clients access to one of the most intuitive and innovative EDC technology suites available on the market today.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 378

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 340

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 63

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 247

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 505

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 262

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 425

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 48

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 456

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 468

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading

Top 5 Most Recently Viewed Articles

C3is Inc (CISS) Hits 52-Week Low; Analyzing Market Challenges

Updated Category News Views 210

C3is Inc (CISS) hit a new low recently, dropping to $1.09 a share. This marks a staggering 97.53% decline over the past year, leaving investors scratching their heads about where this company is headed next. C3is Inc: A Company in Crisis As the stock tumbles to its 52-week low, the implications for C3is's market position are glaring. With a market cap of just $6.75...

Continue Reading
Securitas AB Set to Release Q3 2025 Financial Results Soon

Updated Category News Views 308

Securitas AB Announces Release of Q3 2025 Results STOCKHOLM, Oct. 29, 2025 - Securitas AB is gearing up to publish its Interim Report for the period of January to September 2025 on Thursday, November 6, 2025, at 8:00 a.m. CET. This important financial document will provide insights into the company's performance and outlook for the future. Details of the Report Release...

Continue Reading
XRP Whales Drive Demand for ExoraPad's $EXP as Presale Surges

Updated Category News Views 216

XRP Whales Drive Demand for ExoraPad's $EXP as Presale Surges In a remarkable show of confidence, XRP whales are actively positioning themselves to acquire ExoraPad's $EXP tokens, resulting in a presale that has quickly exceeded expectations. This impressive feat has occurred just hours after the presale launch, where over 30% of the softcap has already been raised,...

Continue Reading
Innovative Partnership for Elderly Services and Board Changes

Updated Category News Views 164

Strengthening Services for the Elderly CLIK is thrilled to announce its exciting new partnership with Flash Mutual, a cutting-edge technology firm operating under Tencent's Sustainable Social Value initiatives. This collaboration is designed to deliver round-the-clock instant device services specifically aimed at enhancing the lives of senior citizens. A Focus on...

Continue Reading
Microsoft's Fourth-Quarter Forecast: Anticipating Growth and Innovation

Updated Category News Views 217

Overview of Microsoft's Upcoming Fourth Quarter Earnings Microsoft Corporation (NASDAQ: MSFT) is positioning itself for a robust financial report as it gears up to share its fourth-quarter results. Analysts are excited about the anticipated growth driven by advancements in AI and cloud services, highlighting the company's impressive trajectory in the tech sphere. Earnings...

Continue Reading